Delving into the Latest Updates on Guangzhou Consun Pharmaceutical Research Co., Ltd. with Synapse

Overview

Tags

Endocrinology and Metabolic Disease

Urogenital Diseases

Herbal medicine

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Disease Domain	Count

Endocrinology and Metabolic Disease	1

Top 5 Drug Type	Count

Herbal medicine	1

To preliminarily evaluate the efficacy and safety of Huangqi Powder Micropills in the treatment of diabetic kidney disease (Qi deficiency syndrome), explore the advantageous dose of Huangqi Powder Micropills in the treatment of diabetic kidney disease, and provide support for the next step of clinical research design.

Start Date31 Jan 2021

Sponsor / Collaborator

Consun Pharmaceutical (Inner Mongolia) Co., Ltd.

[+1]

100 Clinical Results associated with Guangzhou Consun Pharmaceutical Research Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Guangzhou Consun Pharmaceutical Research Co., Ltd.

Login to view more data

100 Deals associated with Guangzhou Consun Pharmaceutical Research Co., Ltd.

Login to view more data

100 Translational Medicine associated with Guangzhou Consun Pharmaceutical Research Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 24 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 2 Clinical

1

Login to view more data